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Abstract
The aim of this prospective randomized clinical study was to compare blood glucose and cortisol levels between horses 
receiving xylazine and detomidine for surgical and non-surgical procedures. Horses from non-surgical groups received 0.5 
mg/kg of xylazine (GX group, n=5) or 0.01 mg/kg of detomidine (GD group, n=5) for gastroscopic examination. Horses from 
the surgical groups received similar doses of xylazine (AX group, n=7) or detomidine (AD group, n=7), followed by anesthetic 
induction with 2 mg/kg of ketamine and 0.05 mg/kg of diazepam for an arthroscopic procedure under isoflurane anesthesia. 
Blood samples were obtained prior to the alpha-2 agonist administration (baseline) and after 10, 30, 60 and 90 minutes. All 
groups had a significant increase in blood glucose from 30 to 90 minutes after alpha-2 agonist administration, compared to 
baseline. After receiving the alpha-2 agonist, the AD group had blood glucose levels (118-150 mg/dL) significantly higher 
than GD (99-119 mg/dL) and AX (97-116 mg/dL) groups. Cortisol had no significant changes within a group. However, 
the AX group had cortisol levels (3.6-3.7 mg/dL) significantly lower than GX group (5.4-5.7 mg/dL) from 30 to 90 minutes 
after xylazine administration. We concluded that blood glucose levels were when detomidine was administered for surgical 
procedure, compared to xylazine also for surgical procedure, and non-surgical procedure. Serum cortisol was minimally 
affected by administration of xylazine and detomidine regardless procedures were surgical or non-surgical. 
Keywords: Alpha-2 agonists. Cortisol. Gastroscopy. Arthroscopy. Horses.
Resumo
O objetivo deste estudo clínico, radomizado e prospectivo, foi comparar as concentrações sanguíneas de glicose e cortisol 
entre equinos recebendo xilazina e detomidina para procedimentos cirúrgicos e não-cirúrgicos. Os equinos dos grupos não-
cirúrgicos receberam 0,5 mg/kg de xilazina (grupo GX, n=5) ou 0,01 mg/kg de detomidina (grupo GD, n=5) para realização 
de exame gastroscópico. Os equinos dos grupos cirúrgicos receberam doses semelhantes de xilazina (grupo AX, n=7) ou 
detomidina (grupo AD, n=7), seguindo-se a indução anestésica com 2 mg/kg de cetamina e 0,05 mg/kg de diazepam para 
realização de procedimento artroscópico durante anestesia com isofluorano. As amostras de sangue foram coletadas antes da 
administração do alfa-2 agonista (basal) e após 10, 30, 60 e 90 minutos. Todos os grupos tiveram um aumento significativo 
da glicemia, a partir de 30 até 90 minutos da administração do alfa-2 agonista, em relação ao basal. Após receber o alfa-2 
agonista, o grupo AD apresentou glicemia (118-150 mg/dL) significativamente maior que os grupos GD (99-119 mg/dL) 
e AX (97-116 mg/dL). Não houve diferenças significativas da concentração de cortisol dentro de cada grupo. Entretanto, o 
grupo AX apresentou níveis de cortisol (3,6-3,7 mg/dL) significativamente mais baixos que o grupo GX (5,4-5,7 mg/dL), a 
partir de 30 até 90 minutos da administração de xilazina. Concluímos que a glicemia apresentou valor mais elevadoapós a 
administração de detomidina para realização de procedimento cirúrgico, comparado à xilazina administrada também para 
procedimento cirúrgico, e para procedimento não-cirúrgico. A concentração sérica de cortisol foi minimamente influenciada 
pela administração de xilazina e detomidina independentemente dos procedimentos serem cirúrgicos ou não-cirúrgicos.
Palavras-chave: Alfa-2 agonistas. Cortisol. Gastroscopia. Artroscopia. Equinos.
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Introduction
Horses develop a stress response to anesthesia and 
surgery, characterized by increases in plasma gluco-
corticoids, such as cortisol1,2,3. It commonly increases 
hepatic gluconeogenesis and inhibits glucose uptake 
by the cells,  enhancing lipid-protein catabolism and 
resulting in hyperglycemia4. Therefore, blood glucose 
and cortisol levels may indicate if appropriate analge-
sia is being provided3. 
Alpha-2 agonists drugs (e.g. xylazine and detomi-
dine) are commonly administered in horses for an-
algesia and reduction of the stress response by de-
creasing the sympatho-adrenal activity5,6 and the ad-
renocorticotropic hormone release7. However, these 
drugs also have an anti-insulin effect caused by stim-
ulation of alpha-2 receptors in pancreas, which com-
monly increases blood glucose levels8,9. Therefore, 
this response must be differentiated from the hy-
perglycemia induced by either a sympatho-adrenal 
response to nociceptive stimulus or glucocorticoids, 
when evaluating an analgesic therapy. However, 
there is no single index or variable, or combination 
of variables that consistently makes this differentia-
tion by defining a stress response10. A traditional ap-
proach includes measurement of both blood glucose 
and cortisol levels5,6,7,8,9. 
Detomidine has a higher specificity for the alpha-2 
receptors compared to xylazine, which suggests that 
detomidine would induce a more pronounced in-
crease in blood glucose levels. However, the literature 
is not consistent regarding the ultimate effect of the 
association of alpha-2 agonists with different combi-
nations of anesthetic drugs, mechanical ventilation 
and surgery on blood glucose and cortisol levels in 
horses3,4,6,11,12,13,14. In addition, some other determi-
nants of a stress response are also associated with a 
clinical procedure, such as fasting, pain, tissue perfu-
sion and energy availability3,11,12,15,16. All these features 
should be considered to avoid mistakes when inter-
preting blood glucose and cortisol in horses during a 
clinical procedure. 
Therefore the aim of the present study was to 
compare the levels of blood glucose and cortisol in 
horses receiving xylazine or detomidine alone, for 
non-surgical procedures, or in combination with 
ketamine, diazepam and isoflurane for a surgical 
procedure. The hypothesis was that horses receiv-
ing detomidine have a higher increase in blood glu-
cose than those receiving xylazine, regardless of the 
stressful stimuli, and that xylazine and detomidine 
similarly prevent cortisol increase after a surgical or 
a non-surgical procedure. 
Materials and Method
This study was approved by the Institutional Ani-
mal Care Committee (protocol number 1555/2008). 
Client consent was obtained before inclusion of 
any horse into the study. Data of 24 mature male 
and female horses, weighing 439 ± 32 kg, undergo-
ing gastroscopic examination (n=10) or bilateral ar-
throscopic procedures of the tibiotarsal joint for the 
removal of osteochondral fragments and drilling of 
cartilage (n=14) were registered. All procedures were 
performed in the morning period. Exclusion criteria 
comprised animals undergoing gastroscopic exami-
nation lasting more than 30 minutes or arthroscopic 
procedures lasting more than 90 minutes. Only clini-
cally normal horses, based on their medical history, 
physical examination and laboratory analysis (com-
plete blood count, plasmatic fibrinogen and total 
plasmatic protein levels) were included in the study. 
All animals had a 14-gauge catheter (Safelet - Nipro 
Medical Ltda – Sorocaba-SP, Brazil) introduced into 
the right jugular vein to facilitate drug administration 
and blood sampling. Horses scheduled for gastro-
scopic examination were fasted for 18 hours with no 
water access for 12 hours. The exam was performed 
with animals under IV sedation with 0.5 mg/kg of xy-
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lazine (Sedazine - Fort Dodge Animal Health - Fort 
Dodge-IA, USA) (GX group, n = 5) or IV 0.01 mg/
kg of detomidine (Dormium V - Agener União Saúde 
Animal - Embu Guaçu-SP, Brazil) (GD group, n = 5). 
To ensure the random allocation of the horses among 
groups, xylazine or detomidine were administered ac-
cording to a previous randomization, which was per-
formed using a computer program (www.randomiza-
tion.com). Group information was placed in sealed 
manila envelopes numbered from 1 to 10 by a person 
who did not participate in the study. Envelopes were 
opened in a consecutive order at the arrival of the 
horse at the scheduled time.
Horses scheduled for arthroscopic procedures were 
fasted for 12 hours prior to anesthesia, but water was 
available ad libitum. Animals were premedicated with 
IV administration of 0.5 mg/kg of xylazine (Sedazine 
- Fort Dodge Animal Health - Fort Dodge-IA, USA) 
(AX group, n = 7) or IV 0.01 mg/kg of detomidine 
(Dormium V - Agener União Saúde Animal - Embu 
Guaçu-SP, Brazil) (AD group, n = 7). The adminis-
tration of xylazine or detomidine as preanesthetic 
medication was performed according to a previous 
randomization similar to that designed in horses un-
dergoing gastroscopic examination. Ten minutes after 
premedication was administered, anesthesia was in-
duced by 2 mg/kg of ketamine (Dopalen - Vetbrands 
Animal Health – Miramar-FL, USA) with 0.05 mg/
kg of diazepam (Compaz – Cristália – Itapira-SP, 
Brazil) intravenously. After horses were positioned 
in lateral recumbency, orotracheal intubation was 
performed with a cuffed endotracheal tube of ap-
propriate size. Anesthesia was maintained with iso-
flurane (Isoforine – Cristália – Itapira-SP, Brazil) 
at an end tidal concentration of 1.5 – 1.8% in 100% 
oxygen delivered through a large animal rebreathing 
circuit with a microprocessor-controlled anesthesia 
ventilator designed for horses (Línea C – Intermed 
- São Paulo-SP, Brazil). Animals were positioned in 
dorsal recumbency on a foam padding surgical table 
and all horses were mechanically ventilated. The re-
spiratory rate, inspiratory:expiratory ratio and tidal 
volume were monitored (WinTracer version 3.3 beta 
- Intermed - InMetro [Instituto Nacional de Metrolo-
gia, Normalização e Qualidade certification of medi-
cal products compliance OCP 0004 – São Paulo-SP, 
Brazil) and adjusted to maintain the end-tidal carbon 
dioxide between 35 and 45 mmHg (PoetIQ - Criti-
care Systems Inc. - Waukesha-WI, USA). The side 
stream gas analyzer was calibrated before each sur-
gery, and the sampling line was inserted between the 
orotracheal tube and the rebreathing system for con-
tinuous measurement of end-tidal concentrations of 
isoflurane and carbon dioxide. Self-adhesive patches 
were applied to the skin for recording the electrocar-
diogram and heart rate (Viridia CMS 66S - Hewlett-
Packard – Andover-MA, USA). A 22-gauge catheter 
(Safelet - Nipro Medical Ltda – Sorocaba-SP, Brazil) 
was introduced into the facial artery and connected 
to a calibrated pressure transducer zeroed at the level 
of the left atrium. The systolic, diastolic and mean ar-
terial blood pressures were monitored with a multi-
parametric data collection system (Viridia CMS 66S 
- Hewlett-Packard – Andover-MA, USA). Lactated 
Ringer´s solution was administered (10 mL/kg/h) 
throughout the anesthetic procedure. 
All gastroscopic and arthroscopic procedures were 
performed by the same surgeon (LCLCS). The same 
gastroscope was used for each gastroscopic examina-
tion, and the same resection pattern and suture mate-
rial were used for each arthroscopic surgery.
In all groups, venous blood samples were withdrawn 
prior to the alpha-2 agonist administration (baseline) 
and after 10, 30, 60 and 90 minutes. For horses un-
dergoing gastroscopic examination, “10 minutes after 
alpha-2 agonist administration” corresponded to the 
time-point prior to the introduction of the gastroscope 
into the nostril of the horse, “30 minutes” comprised 
the time-point during the gastroscopic examination, 
and “60 and 90 minutes” corresponded to time-points 
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Table 1 - Blood glucose (mg/dL) and serum cortisol levels (mg/dL) of GX, GD, AX 
and AD groups. Data are presented as mean ± SD
Group Baseline
Post alpha-2 agonists (minutes)
10 30 60 90
GX GlucoseCortisol
89 ± 8
4.5 ± 0.8
97 ± 7
5.2 ± 0.7
111 ± 8
5.4 ± 0.4
109 ± 6
5.5 ± 0.8
105 ± 4
5.7 ± 0.9
GD GlucoseCortisol
86 ± 7
4.4 ± 0.7
93 ± 8
4.5 ± 0.7
119 ± 9
5.4 ± 0.8
112 ± 7
5.1 ± 0.9
99 ± 3
4.6 ± 0.7
AX Glucose
Cortisol
86 ± 6
4.5 ± 0.5
95 ± 8
4.4 ± 0.8
116 ± 9
3.6 ± 0.7
103 ± 9
3.7 ± 0.7
97 ± 9
3.6 ± 0.9
AD GlucoseCortisol
88 ± 5
4.1 ± 0.6
99 ± 8
3.9 ± 0.6
150 ± 9
4.3 ± 0.7
133 ± 9
3.4 ± 0.8
118 ± 9
3.3 ± 0.8
GX group: horses undergoing gastroscopic examination after sedation with xylazine (0.5 mg/kg IV); 
GA group horses undergoing gastroscopic examination after sedation with detomidine (0.1 mg/kg IV); 
AX group: horses undergoing arthroscopic procedures after premedication with xylazine (0.5 mg/kg 
IV); AD group: horses undergoing arthroscopic procedures after premedication with detomidine (0.1 
mg/kg IV). Baseline: prior to the alpha-2 agonist administration. For GX and GD groups: “10 minutes 
post alpha-2 agonist” comprised the time-point prior to the introduction of the gastroscope into the 
nostril of the horse; “30 minutes post alpha-2 agonist comprised the time-point during the gastroscopic 
examination; “60 and 90 minutes post alpha-2 agonist” comprised the time-point after the examination 
had ended. For AX and AD groups: “10 minutes after alpha-2 agonist” comprised the time-point prior 
to the induction of anesthesia, “30 minutes” comprised the time-point during 15 minutes of isoflurane 
anesthesia and prior to the start of surgery, and “60 and 90 minutes” comprised the time-points during 
arthroscopic surgery with no drilling of cartilage and with drilling of cartilage, respectively. *Within a 
group, values differ from baseline (P < .05); †within a time-point, values differ from the AD group (P < .05); ‡within a time-point, values differ from the GX group (P < .05). São Paulo/SP, 2009
after the examination had ended. For horses under-
going arthroscopic procedures, “10 minutes after al-
pha-2 agonist” comprised the time-point prior to the 
induction of anesthesia, “30 minutes” comprised the 
time-point during 15 minutes of isoflurane anesthesia 
and prior to the start of surgery, and “60 and 90 min-
utes” comprised the time-points during arthroscopic 
surgery with no drilling of cartilage and with drilling 
of cartilage, respectively.
Blood samples for glucose measurements were im-
mediately analyzed by amperometry in a portable 
glucometer (Accu-Check Aviva - Roche Diagnostics 
Corp. – Indianapolis-IN, USA), which was consid-
ered to have high agreement with the gold standard 
laboratory measurement of glucose in the plasma of 
equine emergency patients17. The samples for cortisol 
measurements were immediately centrifuged and se-
rum was stored at -20oC for posterior evaluation per-
formed by radioimmunoassay (TKCO5 cortisol - Sie-
mens Healthcare Diagnostics - Deerfield-IL, USA).
Statistical Analysis
Blood cortisol and glucose concentrations were 
analyzed within groups (baseline versus 10, 30, 60 
and 90 minutes after alpha-2 agonists administra-
tion) and between groups (GX group versus GD 
group, AX group versus AD group, GX group versus 
AX group and GD group versus AD group) by using 
two-way analysis of variance (InStat 3.01 – Graph-
Pad - San Diego-CA, USA). When appropriate, post 
hoc analysis was performed with Tukey test for anal-
ysis within groups and with t-Student test for analy-
sis among groups. Within each group, the Pearson 
correlation coefficient was calculated between blood 
glucose and serum cortisol levels. A p<0.05 value 
was considered significant.
Results
No significant differences were observed between 
the groups for the baseline values of blood glucose 
and cortisol (Table 1). 
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In all groups, blood glucose increased significantly 
at 30, 60 and 90 minutes after alpha-2 agonist ad-
ministration compared to baseline (p<0.05). Horses 
from the AD group had blood glucose significantly 
higher than horses from the GD and AX groups at 
30 (p=0.0002, p=0.0001, respectively), 60 (p=0.001, 
p =0.0003, respectively) and 90 minutes (p=0.0013, 
p=0.0037, respectively) (Table 1).
No significant serum cortisol increase was observed 
within the groups. Horses from the GX group had 
cortisol levels significantly higher than horses from 
the AX group at 30 (p=0.0003), 60 (p=0.0021) and 
90 minutes (p=0.0023) (Table 1). No significant cor-
relation between blood glucose and cortisol levels was 
observed within or between the groups (GX group: 
r=0.5875, p=0,0631; GD group: r=0.2981, p=0.0629; 
AX group: r=-0.5605, p=0.1355; AD group: r=-
0.02061, p=0.9738).
Discussion
The blood glucose increase is a well-known marked 
effect of alpha-2 agonists1,6,8,9. The present results, 
however, showed that during a surgical procedure and 
combined with other anesthetics, blood glucose levels 
have a higher increase (70%) when followed by deto-
midine (group AD) than after  xylazine (group AX, 
35% increase in blood glucose). 
In part, this finding was attributed to the fact that 
detomidine has a higher specificity for the alpha-2 re-
ceptors (260:1) compared with xylazine (160:1)18, and 
that it is the anti-insulin effect caused by stimulation 
of alpha-2 agonist receptors in pancreas that produces 
the hyperglycaemic effect8,9.  However, the other anes-
thetics and surgical stimuli should also have contrib-
uted for these results, since blood glucose following 
detomidine plus diazepam, ketamine and isoflurane 
for surgery was higher than after detomidine alone 
for a non-surgical procedure (38% increase in blood 
glucose). Indeed, horses in the AD group had blood 
glucose levels higher than the normal range for the 
species (75.6 to 131.4 mg/dL)19. These higher values 
were observed only at 30 and 60 minutes, which can 
be attributed to the action time of detomidine. Ket-
amine administered for induction of anesthesia is a 
sympathomimetic drug that can possibly produce 
significant changes in blood glucose and cortisol1. 
However, previous studies reported that plasma glu-
cose values following 1.1 mg/kg xylazine and 2.2 mg/
kg ketamine were almost identical to those reported 
after xylazine alone8,9.
Although horses are described to develop a stress 
response to anesthesia and surgery1,2,3, this was not 
observed in the present study. However, in previous 
studies only halothane, but not isoflurane, was associ-
ated with a stress response to anesthesia through acti-
vation of the pituitary-adrenal axis, and significantly 
increase of plasma cortisol levels in horses2,13,16,20,21. 
This effect was not reported with isoflurane, which 
was described to produce minimal changes in bio-
chemical and hormonal values in horses undergoing 
surgery1,22. In addition, alpha-2 agonists are capable 
to reduce the stress response in horses5,6. Although 
cortisol levels were lower in the AX group, which un-
derwent surgery, compared to the GX group, which 
did not, these differences probably had little clinical 
relevance, as no significant differences were observed 
within a group.  Benzodiazepine20 and ketamine1,4 ad-
ministered in groups that underwent surgery had no 
significant impact on cortisol levels and this was sup-
ported by previous studies, describing no significant 
changes in cortisol levels of horses receiving detomi-
dine, midazolam and ketamine followed by main-
tenance with isoflurane14. Furthermore, in another 
study, xylazine and ketamine administered prior to 
halothane anesthesia delayed cortisol increase for 80 
minutes13. 
Besides anesthesia, the stress response is also asso-
ciated with the pain stimuli, and reported to be pro-
portional to the degree of surgical trauma12,23. Similar 
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to the present study, Robertson et al.11 also reported 
minor changes in circulating metabolites and hor-
mones in horses undergoing arthroscopic surgery. In 
addition, cortisol levels in the present study were also 
similar to horses undergoing standing laparoscop-
ic cryptorchidectomy24, and general anesthesia for 
non-abdominal surgery1,12. However, as expected, in 
horses undergoing colic surgery, cortisol levels were 
reported to be higher than in the present study25,26.
Baseline values for blood glucose and cortisol levels 
were similar between groups, regardless of the time 
for fasting, and these values were within the range of 
normal values for horses9,15,19,22,27. In addition, diur-
nal variations of cortisol are described to be remark-
able in the horse, considering the circadian pattern 
of cortisol release by adrenal gland27, so only horses 
undergoing procedures in the morning period were 
included in the present study. The greatest blood glu-
cose and cortisol changes occurred at 30 minutes af-
ter administration of alpha-2 agonist in all groups, but 
values higher than baseline were observed until the 
last time-point (90 minutes after administration of 
the alpha-2 agonist). This long-term change in blood 
glucose and cortisol was also reported in previous 
studies in horses11,13.
In conclusion, blood glucose increase was higher in 
the anesthetized group receiving detomidine for a sur-
gical procedure. Cortisol levels were lower in horses 
receiving xylazine for a surgical procedure, compared 
to the non-surgical group, but normal values for cor-
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